Ledger.Open graph →
SEC Form D · filed November 25, 2015

Codiak BioSciences, Inc

Offering
—
Sold
$31.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Steven Gillis · Seattle, WADirectorNoubar Afeyan · Cambridge, MADirectorMarc G. Rubin · Norcross, GADirectorEric Lander · Seattle, WADirectorDoug Williams · Seattle, WAExec · DirectorAaron Silverman · Washington, Washington, D.C.DirectorSteven G. Prelack · Norcross, GADirectorEric Lander · Seattle, WADirectorDoug Williams · Seattle, WAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗